Dr. Prabhanjan Giram
University at Buffalo, State University of New York, Dr.D.Y.Patil Institute of Pharmaceutical Sciences and Research, CSIR-NCL,PUNE
Research areas: Pharmacology, Toxicology and Pharmaceutics · Pharmaceutical Science · Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems · Advancements in Transdermal Drug Delivery
About
With over ten years of experience in pharmaceutics, nanomedicine, and drug delivery, I am a Postdoctoral Associate at the State University of New York at Buffalo, where I design and characterize innovative nanoformulations for photodynamic therapy of various cancers. I collaborate with a multidisciplinary team of researchers, clinicians, and industry partners to optimize nanocarriers such as m-PEG-PLA micelles, liposomes, and LNPs that can deliver anticancer agents, immunostimulants, and prodrugs to the tumor site, enhance their therapeutic efficacy, and reduce their systemic toxicity.
I have a strong academic background and credentials, with a Ph.D. in Polymer Science and Engineering from the National Chemical Laboratory in Pune, India, and multiple publications, patents, and awards. I also received a prestigious Newton Bhabha Fellowship to conduct research at the King's College London, UK, on nanofibrous scaffolds for tissue engineering. I am passionate about advancing the field of nanomedicine and contributing to the development of safe and effective treatments for patients with cancer. As an Adjunct Professor at Dr.D.Y.PATIL INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH PIMPRI, I also share my knowledge and skills with the next generation of pharmacists and scientists.
Employment
-
University at Buffalo Post Doctoral Fellow2021 - Present
-
Dr.D.Y.Patil Institute of Pharmaceutical Sciences and Research Assistant Professor2019 - 2021
Education
-
CSIR-NCL,PUNE PhD2014 - 2018
Projects & Funding
Projects & funding information is unavailable.
Publications (42)
- Single‐treatment in situ photo‐vaccination with paclitaxel prodrug‐PDT enables durable local and abscopal tumor control in a bilateral Colon 26 model Save
- Lecithin-Coated PLGA Nanoparticles for Pulmonary Targeting of Naringin: Formulation, Optimization and In Vitro Characterization Save
- Recent Advances in Polyurethane Polymer for Biomedical Applications Save
- In Situ Cancer Vaccines: Redefining Immune Activation in the Tumor Microenvironment Save
- Development of Voriconazole Proliposome Based Dry Powder for Inhalation: A Design of Experiment Approach Save
- Electrospun nanofibers: a promising paradigm for biomedical applications Save
- Development of Quercetin Micellar Nanogel: Formulation, Characterization, and In Vitro Cytotoxocity Study Save
- Core-shell structured gold nanoparticles: From synthesis to applications Save
- Engineered PLGA Core–Lipid Shell Hybrid Nanocarriers Improve the Efficacy and Safety of Irinotecan to Combat Colon Cancer Save
- Lecithin Organogel: A Promising Carrier for the Treatment of Skin Diseases Save
- Advanced polymeric dendrimers in the management of Alzheimer's disease Save
- Poly(d,l-lactide-co-glycolide) Surface-Anchored Biotin-Loaded Irinotecan Nanoparticles for Active Targeting of Colon Cancer Save
- Polyelectrolyte-Complex-Based Hydrogel Inserts for Vaginal Delivery of Posaconazole and Probiotics Save
- Green Tea Extract Solid Dispersion Pellets with Enhanced Permeability for Hyperlipidemia Save
- Polycaprolactone and its derivatives for drug delivery Save
- Formulation Development and Evaluation of Indian Propolis Hydrogel for Wound Healing Save
- Nanomaterials in Cosmetics: An Outlook for European Regulatory Requirements and a Step Forward in Sustainability Save
- Photodynamic Therapy for Bladder Cancers, A Focused Review† Save
- A Systematic Overview of Eudragit® Based Copolymer for Smart Healthcare Save
- Progress on Thin Film Freezing Technology for Dry Powder Inhalation Formulations Save